BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,951,442 | -19.7% | 157,696 | -3.0% | 0.62% | -15.6% |
| Q2 2023 | $7,408,346 | +8.2% | 162,606 | -3.7% | 0.74% | +2.1% |
| Q1 2023 | $6,848,828 | -20.0% | 168,857 | +0.6% | 0.72% | -22.7% |
| Q4 2022 | $8,559,260 | -5.4% | 167,927 | -0.1% | 0.93% | -15.0% |
| Q3 2022 | $9,050,000 | -13.0% | 168,021 | +3.7% | 1.10% | -6.9% |
| Q2 2022 | $10,408,000 | -17.4% | 162,049 | -0.3% | 1.18% | -3.2% |
| Q1 2022 | $12,600,000 | -9.8% | 162,497 | -0.1% | 1.22% | -1.3% |
| Q4 2021 | $13,965,000 | +7.1% | 162,690 | +0.3% | 1.23% | -2.1% |
| Q3 2021 | $13,044,000 | +2.6% | 162,178 | +2.7% | 1.26% | +3.2% |
| Q2 2021 | $12,718,000 | -4.9% | 157,986 | -0.4% | 1.22% | -10.0% |
| Q1 2021 | $13,378,000 | +6.4% | 158,623 | +1.2% | 1.36% | -2.5% |
| Q4 2020 | $12,576,000 | -0.7% | 156,733 | -0.5% | 1.39% | -8.4% |
| Q3 2020 | $12,667,000 | -5.9% | 157,511 | +0.7% | 1.52% | -14.5% |
| Q2 2020 | $13,461,000 | +7.6% | 156,339 | +1.5% | 1.78% | -10.0% |
| Q1 2020 | $12,511,000 | -5.0% | 154,100 | -2.1% | 1.97% | +20.5% |
| Q4 2019 | $13,165,000 | -2.2% | 157,437 | +2.3% | 1.64% | -8.4% |
| Q3 2019 | $13,466,000 | +7.6% | 153,952 | +0.8% | 1.79% | +3.2% |
| Q2 2019 | $12,512,000 | +0.1% | 152,776 | -0.7% | 1.73% | -3.5% |
| Q1 2019 | $12,505,000 | +21.0% | 153,791 | -2.0% | 1.80% | +12.4% |
| Q4 2018 | $10,332,000 | -16.3% | 156,983 | -2.0% | 1.60% | -2.7% |
| Q3 2018 | $12,347,000 | +6.1% | 160,157 | +1.6% | 1.64% | -3.0% |
| Q2 2018 | $11,640,000 | +13.6% | 157,638 | +0.1% | 1.70% | +11.4% |
| Q1 2018 | $10,246,000 | -0.1% | 157,524 | -0.8% | 1.52% | +5.3% |
| Q4 2017 | $10,259,000 | +3.6% | 158,724 | +0.6% | 1.45% | -3.3% |
| Q3 2017 | $9,899,000 | +3.9% | 157,760 | +0.2% | 1.50% | +1.5% |
| Q2 2017 | $9,531,000 | +17.1% | 157,444 | +0.3% | 1.47% | +15.1% |
| Q1 2017 | $8,140,000 | +17.6% | 156,964 | +0.6% | 1.28% | +10.7% |
| Q4 2016 | $6,921,000 | -7.0% | 156,089 | -0.2% | 1.16% | -8.8% |
| Q3 2016 | $7,443,000 | +5.6% | 156,379 | +0.3% | 1.27% | +3.8% |
| Q2 2016 | $7,049,000 | +10.2% | 155,902 | +0.1% | 1.22% | +7.4% |
| Q1 2016 | $6,397,000 | +7.7% | 155,716 | +0.1% | 1.14% | +4.4% |
| Q4 2015 | $5,938,000 | +17.6% | 155,636 | +1.3% | 1.09% | +10.0% |
| Q3 2015 | $5,048,000 | -51.8% | 153,680 | +2.6% | 0.99% | -49.0% |
| Q2 2015 | $10,476,000 | +6.8% | 149,809 | +4.7% | 1.94% | +4.5% |
| Q1 2015 | $9,806,000 | -2.7% | 143,151 | +4.1% | 1.86% | -5.2% |
| Q4 2014 | $10,078,000 | +3.4% | 137,500 | +1.3% | 1.96% | -0.8% |
| Q3 2014 | $9,744,000 | +1.4% | 135,774 | +2.2% | 1.98% | +0.3% |
| Q2 2014 | $9,607,000 | +1.0% | 132,872 | +2.8% | 1.97% | -4.6% |
| Q1 2014 | $9,509,000 | +7.8% | 129,231 | +1.9% | 2.06% | +5.2% |
| Q4 2013 | $8,819,000 | +8.1% | 126,793 | +2.1% | 1.96% | -1.0% |
| Q3 2013 | $8,159,000 | -0.0% | 124,206 | +5.4% | 1.98% | -2.8% |
| Q2 2013 | $8,160,000 | – | 117,799 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |